| Ceplene (histamine dihydrochloride) |
Abstract
pdf
|
|
Business Review Editor |
|
| Mundipharma to Develop Sosei’s Fentanyl Pain Spray |
Abstract
pdf
|
|
Business Review Editor |
|
| J&J Active on the Deal Front |
Abstract
pdf
|
|
Business Review Editor |
|
| Medivir Refocuses its Pipeline via Tibotec Deals |
Abstract
pdf
|
|
Business Review Editor |
|
| Diagnosing Change: Celera Genomics' Strategic Drug Sell-Off |
Abstract
pdf
|
|
Business Review Editor |
|
| Deal Making Review: 2000-2005, with Projections for 2006 |
Abstract
pdf
|
|
Business Review Editor |
|
| Therapy Focus: Atherosclerosis |
Abstract
pdf
|
|
Business Review Editor |
|
| Mayne Pays US$34 M for Rights to SuperGen Oncology |
Abstract
pdf
|
|
Business Review Editor |
|
| Nastech and Amylin Sign Deal for Diabetes Nasal Spray |
Abstract
pdf
|
|
Business Review Editor |
|
| Vertex Views Success on the Horizon |
Abstract
|
|
Business Review Editor |
|
| CrystaX Pharmaceuticals SL |
Abstract
|
|
Business Review Editor |
|
| Barr and Actavis Battle for PLIVA |
Abstract
pdf
|
|
Business Review Editor |
|
| The Culture of Deal Making |
Abstract
html
|
|
Fintan Walton |
|
